Five-year Molecular Response and Overall Survival with First- and Second-Generation Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia in the Chronic Phase: a Prospective, Observational Study - SIMPLICITY.
Leukemia & lymphoma（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined